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Lack of Association Between HLA 
Antigen DR3 and a,l-Antitrypsin Deficiency 
in Liver Transplant Recipients 
ADRIAN CASAVILLA, MD, ROBERT GORDON, MD, DAVID H. VAN THIEL, MD, and 
THOMAS E. ST ARZL, MD, PhD 
The relationship between arantitrypsin deficiency (arATD) and the HLA antigen system 
was studied in 32 liver transplant recipients. Despite previous reports of an association of 
HLA antigen DRJ with homozygosity for arA T ZZ, no such association was seen in this 
population of arATD homozygous ZZpatients with advanced hepatic disease. Thus, the 
reported association of HLA class II antigens and homozygosity for the Z allele for arAT 
may be an artifact of either a small study population or geographic inbreeding and a 
coincidental association of certain HLA antigens with the presence of homozygosity for 
the Z allele of arAT. 
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Liver transplantation is a life-saving therapy for 
individuals with end-stage liver disease for whom 
medical therapy does not exist (1-7). These individ-
uals by definition represent the worse cases. Should 
an association between the presence of a given liver 
disease and certain HLA antigens exist. such an 
association would be expected to be readily demon-
strable in individuals with the most severe disease, 
such as those requiring liver transplantation. The 
demonstration of such an association in liver trans-
plant recipients with a given disease would be ex-
pected to occur as a result of a selection bias in 
which the more severely diseased cases are identi-
fied and selectively referred for transplantation. 
Therefore. in order to either confirm or refute the 
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reported aSSOCIatIon between HLA antigen DR3 
with a1-ATD (homozygosity for the Z allele). the 
following study was performed. 
MATERIALS AND METHODS 
Between January I. 1980, and December 31. 1990. a 
total of 2500 liver transplants were performed at the 
University of Pittsburgh Medical Center (UPMC). Of 
these. 1888 were adult cases and 612 were pediatric cases. 
During this time, 47 patients with a,-ATD homozygous 
ZZ were seen and transplanted. Of this group, 32 (68%) 
underwent HLA typing prior to their transplant and were 
utilized for the analysis that follows: 18 were male and 14 
were female. Their ages ranged from 10 months to 57 
years (mean 15.65 ± 14.6). 
- In each case, the diagnosis of al-ATD was confirmed 
by quanti tat ion of the serum aI-AT level and determina-
tion of the Pi phenotype and as a result of family studies 
(8-10). 
at-Antitrypsin Studies. For the quantitative assay, se-
rum levels of a-I-AT were quantitated by rate nephelom-
etry using the Beckman Array Protein System (8, 9). 
Normal levels at UPMC are 85-213 mg/dl. Determination 
of the aI-AT Pi phenotype was performed using isoelec-
tric focusing on agarose gel (10). Standards were utilized 
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TABLE \. PREVALENCE OF HLA ANTIGEN DR3 IN PATIENTS 
COMING TO OLTx FOR ai-ANTITRYPSIN DEFICIENCY (PI ZZ 
PHENOTYPE) 
Adults (N = 11) 
Children (N = 21) 
Total al-ATD (N = 32) 
Pittsburgh controls (N = 200) 
DRJ 
(%) 
9.0 
9.5 
9.4 
22.5 
in each run_ For family studies, whenever possible the 
patients' siblings, parents, and children were studied to 
confirm the at-AT phenotype. 
HLA Typing. HLA typing was performed using lym-
phocytes isolated from the peripheral blood of each indi-
vidual utilizing a standard NIH microlymphocytotoxicity 
assay and an immunomagnetic fluorescence technique for 
the DR typing (11, 12). 
Liver Histology. The pathological findings of the re-
sected livers were characterized grossly and by a histo-
logic examination performed by staff pathologists at Pres-
byterian University and Children's Hospital of Pittsburgh. 
The records of these examinations were reviewed. 
Statistical Analysis. All values are reported as mean :t 
SEM. Statistical analyses were performed utilizing chi-
square analysis; P < 0.05 was considered significant. 
RESULTS 
Twenty-one children having a mean age of 6.8 ± 
3.6 years and 11 adults having a mean age of 32.5 ± 
12.8 years with (XI-AID and ZZ phenotype were 
studied. They represent 0.3% of the children and 
0.6% of the adults transplanted at the University of 
Pittsburgh Medical Center during the lO-year period 
of this study. 
HLA Antigens. The prevalence of HLA antigen 
DR3 in a control group of 200 normal blood donors 
in Pittsburgh was 22.6%. The prevalence of this 
antigen in the 32 patients studied as part of this 
investigation is shown in Table 1. Whether one 
looks at the cases in adults, children, or all of the 
cases transplanted for al-A TO, a reduced preva-
lence of DR3 was found as compared to a normal 
control popUlation. None of these differences are 
significant. 
ai-Antitrypsin Levels_ The serum (X)-AT level of 
these 32 patients as well as those of a group of liver 
disease controls consisting of 22 adults and 44 chil-
dren matched for age (two for each case with al-
ATD) also transplanted at the University of Pitts-
burgh Medical Center during the study period is 
shown in Table 2. As expected, the patients with 
(XI-A TO had very low levels of the protease inhibi-
lOr in their sera prior to OLTx. In contrast. com-
1490 
CASA VILLA ET AL 
TABLE 2. ai-ANTITRYPSIN LEVELS (MEAN VALUES) AT TIME Of 
OLTx 
Adults (N = 11) 
Children (N = 21) 
Liver disease controlst 
Children (N = 44) 
Adults (N = 22) 
Normal conlrols (N = 200) 
arAT (mgldl) 
38.4 ± 2.3' 
34.7 ± 1.8' 
200.9 ± 10.8* 
149 ± 6.4 
'P < 0.01 from both normal controls and liver disease controls. 
tlndividuals coming to OLTx for conditions other than al-ATD. 
if> < 0.01 from the normal controls. 
pared to normal controls, the non-(Xt-AID cases 
coming to OLTx had increased serum levels of 
(Xt-AT. 
Liver Histology. The histological findings of the 32 
cases studied are reported in Table 3. Of interest is 
the fact that no case of (XI-AT was found to have a 
cholangiocarcinoma and only one pediatric patient 
was found to have a hepatoma. These figures stand 
in contrast to the 2% incidence of hepatocellular 
carcinoma in adults transplanted for hepatocellular 
disease other than (Xt-A TD and the 0.75% rate for all 
other children coming to OLTx. 
DISCUSSION 
In a study performed by Doherty et al (13), it was 
reported that DR3 occurs more frequently in pa-
tients with (XI-AID having a liver disease, suggest-
ing that in these patients this allele may influence 
the outcome of the liver disease seen as part of the 
greater spectrum of (XI-A TD disease. 
Doubts about such an association in individuals 
with (XI-AID arose when other groups such as those 
of Nemeth and Moller (14) could not confirm the 
association of this allele with development of liver 
disease in children with (XI-AID. 
To resolve this controversy, the present study 
was initiated. Because of the relative rarity of ho-
TABLE 3. FREOUENCY Of HEPATIC CANCER IN 32 CASES 
STUDIED COMPARED TO ll-IAT OcCURRING IN OTHER TyPES OF 
CIRRHOSIS 
Cirrhosis Hepatoma Cholanglolar CA 
(%) (%) (%) 
Adults (N = II) 100 0 0 
with al·ATD 
Children (N = 21) 100 5 0 
with al-ATD 
Other adults coming 100 :! 0 
to OLTx for PNC 
Other children 0 0.75 0 
coming to OL Tx 
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mozygous ZZ aI-AID as a cause of clinical liver 
disease and because of the large number of HLA 
antigens that are recognized to exist currently, the 
present study was biased in favor of finding an 
association by examining only the HLA antigen 
present in individuals with a1-ATD coming to 
OLTx. Specifically, we selected the poorer cases 
for study. Were an association between certain 
HLA antigens and aI-AID liver disease to exist, 
one would have expected an enrichment of these 
HLA antigens in a population of individuals with 
liver disease sufficiently severe as to be referred for 
liver transplantation. Such would appear to be the 
case for other liver disease like autoimmune chronic 
active hepatitis, sclerosing cholangitis, and chronic 
HBV-related liver disease (15-19). Despite this bias 
in the accrual of subjects for this study, no associ-
ation between any HLA antigens and particularly 
DR3 was found in either children or adults or both 
groups combined having aI-AID liver disease con-
firmed by quantitation of the serum aI-AT level, 
isoelectric focusing for phenotype analysis, and 
family studies of the probands as well as having a 
need for OLTx. Therefore, based upon this biased, 
worst-case population, no association between 
HLA antigen DR3 and aI-AID liver disease ap-
pears to exist. 
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